Comparison of Two Pain-treatment Techniques After Tympanomastoid Surgery Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-05

Study Completion Date

2017-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analgesia following tympanomastoid surgery is critical for the prevention of postoperative . There are very few regional anesthesia methods used to achieve this goal.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparative Study Between Ultrasound Guided Regional Anesthesia for Awake Tympanoplasty Surgery vs General Anesthesia

NCT07275450

Ultrasound Guided Nerve Block Anesthesia , Analgesia

RECRUITING NA

Pecto-Intercostal Fascial Block vs. Transversus Thoracic Muscle Plane Block in Cardiac Surgery

NCT04791592

Pain, Postoperative Coronary Artery Disease

COMPLETED NA

Effect of the Superficial Cervical Plexus Block in the Hypotensive Anesthesia of Ear Surgery.

NCT07241364

Pain After Surgery

ACTIVE_NOT_RECRUITING NA

Comparative Study of Ultrasound-guided Paravertebral Block Versus Intravenous Tramadol in Percutaneous Nephrolithotomy

NCT02412930

Postoperative Pain

COMPLETED PHASE4

Postoperative Analgesis for Pain Management After Thoracotomy

NCT06177652

Postoperative Pain Analgesia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, it was aimed to investigate the effect of Ultrasound guided superficial cervical plexus block versus greater auricular nerve block for on postoperative tympanomastoid surgery analgesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management Nerve Block Ultrasound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

prospective,randomized,single blind

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Grup Y

ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine+IV patient-controlled analgesia (PCA) tramadol

Group Type ACTIVE_COMPARATOR

IV patient-controlled analgesia (PCA) tramadol

Intervention Type DRUG

Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

ultrasound guided superficial cervical plexus block

Intervention Type DRUG

ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine

Grup B

ultrasound ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol

Group Type ACTIVE_COMPARATOR

IV patient-controlled analgesia (PCA) tramadol

Intervention Type DRUG

Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

ultrasound guided Great Auricular nerve block

Intervention Type DRUG

ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IV patient-controlled analgesia (PCA) tramadol

Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Intervention Type DRUG

ultrasound guided superficial cervical plexus block

ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine

Intervention Type DRUG

ultrasound guided Great Auricular nerve block

ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tramadol superficial cervical plexus block Great Auricular nerve block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were in the American Society of Anesthesiologists (ASA) I-III class and underwent Tympanomastoid surgery.

Exclusion Criteria

* Previous history of opioid use preoperatively,
* Allergy to local anesthetics,
* The presence of any systemic infection,
* Uncontrolled arterial hypertension,
* Uncontrolled diabetes mellitus.

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No